Correlation Between Trevi Therapeutics and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Alx Oncology Holdings, you can compare the effects of market volatilities on Trevi Therapeutics and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Alx Oncology.
Diversification Opportunities for Trevi Therapeutics and Alx Oncology
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Trevi and Alx is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Alx Oncology go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Alx Oncology
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.58 times more return on investment than Alx Oncology. However, Trevi Therapeutics is 1.72 times less risky than Alx Oncology. It trades about -0.14 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.11 per unit of risk. If you would invest 436.00 in Trevi Therapeutics on November 2, 2024 and sell it today you would lose (46.00) from holding Trevi Therapeutics or give up 10.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Trevi Therapeutics vs. Alx Oncology Holdings
Performance |
Timeline |
Trevi Therapeutics |
Alx Oncology Holdings |
Trevi Therapeutics and Alx Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Trevi Therapeutics and Alx Oncology
The main advantage of trading using opposite Trevi Therapeutics and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |